Virginia Retirement Systems Et Al Vir Biotechnology, Inc. Transaction History
Virginia Retirement Systems Et Al
- $10.1 Billion
- Q3 2023
A detailed history of Virginia Retirement Systems Et Al transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 56,900 shares of VIR stock, worth $417,077. This represents 0.01% of its overall portfolio holdings.
Number of Shares
56,900
Previous 39,900
42.61%
Holding current value
$417,077
Previous $978,000
45.5%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding VIR
# of Institutions
218Shares Held
87MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$122 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$96.3 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$41.2 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$26.2 Million0.63% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $972M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...